36 citations · 36 across the 2 of their papers we have counts for
2 papers
stat.AP2022
Time-to-event estimands and loss to follow-up in oncology in light of the estimands framework
Jonathan Siegel, Hans-Jochen Weber, Stefan Englert +1
Time-to-event estimands are central to many oncology clinical trials. The estimand framework (addendum to the ICH E9 guideline) calls for precisely defining the treatment effect of…
q-bio.OT2020★ 36 cited
Assessing the Impact of COVID-19 on the Objective and Analysis of Oncology Clinical Trials -- Application of the Estimand Framework
Evgeny Degtyarev, Kaspar Rufibach, Yue Shentu +10
COVID-19 outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and it…